[1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate

C26H31F3N4O5S2 — CID 121311795

IUPAC[1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate
SMILESCC[C@H](NS(=O)(=O)c1ccc(-c2sc(-c3nnc(CC(C)(C)OC=O)o3)nc2CC2CCC2)c(C)c1)C(F)(F)F
InChIInChI=1S/C26H31F3N4O5S2/c1-5-20(26(27,28)29)33-40(35,36)17-9-10-18(15(2)11-17)22-19(12-16-7-6-8-16)30-24(39-22)23-32-31-21(38-23)13-25(3,4)37-14-34/h9-11,14,16,20,33H,5-8,12-13H2,1-4H3/t20-/m0/s1
InChIKeyCRAXVXXCCSEAJR-FQEVSTJZSA-N
MW600.69 g/mol
LogP5.62
Rot. Bonds12

About [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate

[1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate (PubChem CID 121311795) has the molecular formula C26H31F3N4O5S2 and a molecular weight of 600.69 g/mol. Its IUPAC name is [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate.

Molecular Properties

Compound Name[1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate
PubChem CID121311795
Molecular FormulaC26H31F3N4O5S2
Molecular Weight600.69 g/mol
Exact Mass600.17
IUPAC Name[1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate
SMILESCC[C@H](NS(=O)(=O)c1ccc(-c2sc(-c3nnc(CC(C)(C)OC=O)o3)nc2CC2CCC2)c(C)c1)C(F)(F)F
InChIInChI=1S/C26H31F3N4O5S2/c1-5-20(26(27,28)29)33-40(35,36)17-9-10-18(15(2)11-17)22-19(12-16-7-6-8-16)30-24(39-22)23-32-31-21(38-23)13-25(3,4)37-14-34/h9-11,14,16,20,33H,5-8,12-13H2,1-4H3/t20-/m0/s1
InChIKeyCRAXVXXCCSEAJR-FQEVSTJZSA-N
XLogP5.62
TPSA124.28 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds12
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500600.69
LogP ≤ 55.62
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate?
The IUPAC name of [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate (CID 121311795) is [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate.
What is the SMILES notation for [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate?
The canonical SMILES for [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate is CC[C@H](NS(=O)(=O)c1ccc(-c2sc(-c3nnc(CC(C)(C)OC=O)o3)nc2CC2CCC2)c(C)c1)C(F)(F)F.
What is the InChIKey of [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate?
The InChIKey is CRAXVXXCCSEAJR-FQEVSTJZSA-N. The full InChI is InChI=1S/C26H31F3N4O5S2/c1-5-20(26(27,28)29)33-40(35,36)17-9-10-18(15(2)11-17)22-19(12-16-7-6-8-16)30-24(39-22)23-32-31-21(38-23)13-25(3,4)37-14-34/h9-11,14,16,20,33H,5-8,12-13H2,1-4H3/t20-/m0/s1.
What are the key properties of [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate?
[1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate has a molecular weight of 600.69 g/mol, XLogP of 5.62, 12 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[5-[4-(cyclobutylmethyl)-5-[2-methyl-4-[[(2S)-1,1,1-trifluorobutan-2-yl]sulfamoyl]phenyl]-1,3-thiazol-2-yl]-1,3,4-oxadiazol-2-yl]-2-methylpropan-2-yl] formate is sourced from PubChem (CID 121311795), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).